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We recently reported that diacylglycerol kinase (DGK) a enhanced tumor necrosis factor-a (TNF-
a)-induced activation of nuclear factor-jB (NF-jB). However, the signaling pathway between
DGKa and NF-jB remains unclear. Here, we found that small interfering RNA-mediated knock-
down of DGKa strongly attenuated protein kinase C (PKC) f-dependent phosphorylation of a large
subunit of NF-jB, p65/RelA, at Ser311 but not PKCf-independent phosphorylation at Ser468 or
Ser536. Moreover, knockdown and overexpression of PKCf suppressed and synergistically
enhanced DGKa-mediated NF-jB activation, respectively. These results strongly suggest that DGKa
positively regulates TNF-a-dependent NF-jB activation via the PKCf-mediated Ser311 phosphory-
lation of p65/RelA.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.2+1. Introduction
It is well recognized that a variety of lipid second messengers
that are present in low abundance perform speciﬁc tasks during a
wide range of biological processes in eukaryotic cells. It is
essential that the cellular concentrations of such signaling lipids
are strictly regulated by the action of metabolic enzymes.
Diacylglycerol kinase (DGK) phosphorylates diacylglycerol to
yield phosphatidic acid [1–4]. Diacylglycerol is an established
activator of conventional and novel protein kinase Cs (PKCs),
Unc-13, and Ras guanyl nucleotide-releasing protein [5,6]. Phos-
phatidic acid has also been reported to regulate a number of
signaling proteins, such as phosphatidylinositol-4-phosphate
5-kinase, Ras GTPase-activating protein, Raf-1 kinase, and
atypical PKC [1–4,7].
Mammalian DGK is known to exist as a large protein family
consisting of ten isozymes classiﬁed into ﬁve subtypes according
to their structural features [1–4]. The type I DGKs (a-, b-, andchemical Societies. Published by E
een ﬂuorescent protein; IjB,
tor-jB; PKC, protein kinase C;
factor-a
hemistry, Graduate School of
Chiba 263-8522, Japan. Fax:
ne).c-isozymes) contain two sets of Ca -binding EF-hand motifs at
their N-termini. We recently demonstrated that DGKa is a
novel positive regulator of nuclear factor-jB (NF-jB), which sup-
presses tumor necrosis factor-a (TNF-a)-induced melanoma cell
apoptosis [8]. However, it is not yet known how DGKa activates
NF-jB.
NF-jB is a heterodimeric transcription factor that is predomi-
nantly composed of the 65 and 50 kDa subunits of the Rel family
[9,10]. In resting cells, NF-jB is mainly retained in the cytoplasm
by the inhibitor of NF-jB (IjB) family of proteins, which mask
the nuclear translocation signal of the transcription factor. Upon
cell stimulation, two deﬁned serine residues in the N-terminus of
IjB proteins are phosphorylated by IjB kinase (IKK), thus trigger-
ing their ubiquitination and subsequent degradation by the 26S
proteasome. In this manner, the NF-jB proteins are released for
translocation to the nucleus and subsequent induction of a variety
of jB-dependent genes. Conformational changes by phosphoryla-
tion of p65 (also called RelA) are also important for the activation
of NF-jB [9,10]. For example, in addition to IjB, IKKs phosphory-
late p65 at Ser468 and Ser536 [11,12]. PKCf was reported to di-
rectly phosphorylate p65 at Ser311 in a TNF-a-dependent
manner [13]. In this case, however, factor(s) upstream of PKCf re-
main unclear.
Here we present several lines of evidence indicating that DGKa
positively regulates the PKCf-mediated Ser311 phosphorylation of
p65 in response to TNF-a. We propose that DGKa is a novel key
regulator in the TNF-a–PKCf–NF-jB pathway.lsevier B.V. All rights reserved.
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Fig. 1. Effects of DGKa knockdown on TNF-a-induced phosphorylation of IjBa in
AKI melanoma cells. (A) AKI melanoma cells were transfected with control siRNA or
siRNA (10 nM) targeting DGKa as indicated. After 48 h, the cells were further
incubated with or without 50 ng/ml TNF-a for 5 min and harvested. Cell lysates
(10 lg protein) were analyzed by Western blotting with antibodies against
phospho-IjBa (pIjBa), IjBa, and DGKa as indicated. The relative intensities of
bands of phospho-IjBa (B) and DGKa (C) are shown. The results are presented as
the percentage of the value for control siRNA (TNF-a (+)) and represent the
mean ± S.D. of the values obtained in three separate experiments.
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2.1. Cell culture
AKI cells were maintained as described previously [8].
2.2. Antibodies
Anti-pig DGKa polyclonal antibody (cross-reactive with the hu-
man enzyme) was prepared as described previously [14]. Anti-NF-
jB p65 mouse monoclonal (F-6), anti-phospho-IjBamouse mono-
clonal (B-9), anti-PKCf rabbit polyclonal (C-20), anti-actin goat
polyclonal (C-11), and anti-green ﬂuorescent protein (GFP) mouse
monoclonal (B-2) antibodies were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA). Rabbit polyclonal anti-IjBa and anti-
phospho-NF-jB p65 Ser468 and Ser536 antibodies were obtained
from Cell Signaling Technology (Beverly, MA). Anti-NF-jB p65
phospho-Ser311 rabbit polyclonal antibody was from Abcam (Ab-
cam, Tokyo, Japan).
2.3. Plasmids
Human PKCf cDNA was ampliﬁed by PCR using human whole
brain cDNA (Clontech-Takara Bio, Tokyo, Japan) as template and
then subcloned into the pEGFP-C3 expression vector (Clontech-
Takara Bio). The authenticity of the cDNA construct was conﬁrmed
by DNA sequencing. The expression plasmid of GFP-tagged porcine
DGKa was prepared as described previously [8]. Cells were tran-
siently transfected with cDNAs using Effectene transfection re-
agent (Qiagen, Tokyo, Japan) according to the manufacturer’s
instructions.
2.4. RNA interference
The following small interfering RNA (siRNA) oligonucleotides
were used to knockdown the expression of endogenous DGKa or
PKCf: DGKa Stealth Select RNAiTM (Invitrogen, Tokyo, Japan, catalog
numbers HSS102626 and HSS102627, here designated DGKa#1
and DKGa#2, respectively); PKCf Validated Stealth RNAiTM (Invitro-
gen; catalog number, VHS41533); and Stealth RNAiTM Negative Con-
trol Med GC Duplex (Invitrogen; catalog number, 12935-300). AKI
cells were transfected with these siRNAs using LipofectamineTM
RNAiMAX Reagent (Invitrogen) according to the manufacturer’s
instructions.
2.5. Western blot analysis
Western blotting was performed as described previously [8].
2.6. Luciferase reporter assay
The luciferase reporter assay was performed as described previ-
ously [8].3. Results
3.1. DGKa does not affect phosphorylation of IjB
It is well known that IjB proteins are phosphorylated by IKKs in
response to TNF-a. Thus, to investigate how DGKa activates NF-jB,
we ﬁrst examined TNF-a-induced phosphorylation levels of IjB in
DGKa-silenced AKI cells. In control cells, TNF-a strongly enhanced
the phosphorylation of IjBa (Fig. 1A and B). When DGKa was
knocked down (Fig. 1C), the phosphorylation level was not signif-
icantly changed (Fig. 1A and B). Moreover, we conﬁrmed that pro-tein levels of IjBa were not markedly altered by the DGKa
knockdown (Supplementary Fig. 1). These results indicate that
DGKa is not involved in the phosphorylation of IjBa.
3.2. DGKa enhances phosphorylation of p65 at Ser311 but not at
Ser468 or Ser536
Because phosphorylation of a large subunit of NF-jB, p65 (also
called RelA), is also essential for NF-jB activation [9,10], we next
investigated phosphorylation levels of p65. Ser468 and Ser536 in
p65 were reported to be phosphorylated by IKKs [11,12]
(Fig. 2A), which also phosphorylate IjB. However, silencing of
DGKa failed to affect the phosphorylation levels of Ser468 and
Ser536 (Fig. 2B). Phosphorylation of Ser311 in p65 is also known
to be required for NF-jB activation [13] (Fig. 2A). Intriguingly,
knockdown of DGKamarkedly decreased the phosphorylation lev-
els of Ser311 (Fig. 2B and C). We conﬁrmed that expression levels
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Fig. 2. Effects of DGKa knockdown on TNF-a-induced phosphorylation of NF-jB
p65 subunit in AKI melanoma cells. (A) Schematic diagram of the NF-jB p65
subunit. Several serine residues phosphorylated by TNF-a stimulation are shown.
NLS, nuclear localization sequence; SD, subdomain; TAD, transactivation domain.
(B) DGKa-knockdown AKI melanoma cells were treated as described in Fig. 1. TNF-
a-induced phosphorylation of p65 was analyzed by Western blotting with
antibodies against phosphoserines of p65 (pSer311, pSer468, and pSer536), p65,
and DGKa as indicated. (C) Relative intensities of bands of phospho-Ser311. Results
are presented as the percentage of the value for control siRNA (TNF-a (+)) and
represent the mean ± S.D. of the values obtained in three separate experiments.
TNF-α
siRNA
– +–+ +–
Co
nt
ro
l
DG
Kα
PK
Cζ
DGKα
p65
p65(pSer311)
PKCζ
p65
DGKα
p65
PKCζ
0
20
40
60
80
100
TNF-α
siRNA
– +–+ +–
Co
nt
ro
l
DG
Kα
PK
Cζ
p<0.005
*
*
Ph
os
ph
or
yl
at
ed
 p
65
at
 S
er
31
1 
(%
)
*
A
B
Fig. 3. Effects of PKCf knockdown on TNF-a-induced phosphorylation of the NF-jB
p65 subunit in AKI melanoma cells. (A) AKI melanoma cells were transfected with
control siRNA, DGKa siRNA (#1), or PKCf siRNA (10 nM) as indicated. After 48 h,
cells were further incubated with or without 50 ng/ml TNF-a for 5 min and
harvested. Cell lysates (10 lg protein) were analyzed by Western blotting with
antibodies against phospho-Ser311-p65, p65, DGKa, and PKCf as indicated. (B)
Relative intensities of bands of phospho-Ser311-p65. Results are presented as the
percentage of the value for control siRNA (TNF-a (+)) and represent the mean ± S.D.
of the values obtained in three separate experiments. Statistical signiﬁcance was
determined using Student’s t-test.
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over, there was no difference between siRNAs #1 and #2, which
recognize different sequences in the DGKa gene, arguing against
an off-target effect of the siRNAs.
3.3. DGKa-dependent phosphorylation of p65 at Ser311 is mediated by
PKCf
Because PKCf was reported to phosphorylate Ser311 of p65
[13], we veriﬁed that this protein kinase indeed participates in
the TNF-a-dependent Ser311 phosphorylation of p65 in AKI cells.
As shown in Fig. 3, siRNA-mediated depletion of PKCf signiﬁcantly
inhibited the Ser311 phosphorylation of p65. The result indicates
that PKCf, at least in part, mediates the Ser311 phosphorylation
of p65 induced by TNF-a in AKI cells.
We next examined whether PKCfmediated the DGKa-regulated
Ser311 phosphorylation of p65 observed in Fig. 2. As previously re-
ported [8], overexpression of DGKa markedly enhanced NF-jBactivity (Fig. 4A). Knockdown of PKCf (Fig. 4B) signiﬁcantly im-
paired the DGKa-mediated enhancement of NF-jB activity
(Fig. 4A). We next checked the effects of overexpression of PKCf
on NF-jB activity enhanced by DGKa overexpression. Although
overexpression of DGKa or PKCf slightly enhanced NF-jB activity,
simultaneous overexpression of these proteins synergistically aug-
mented NF-jB activity (Fig. 4C). These results strongly suggest that
PKCf is involved in DGKa-mediated NF-jB activation.
4. Discussion
We recently demonstrated that DGKa positively regulated TNF-
a-induced activation of NF-jB [8], which suppressed melanoma
cell apoptosis. However, it was not clear how DGKa activated
NF-jB. In this study, we showed that the PKCf-mediated Ser311
phosphorylation of p65 is involved in the positive regulation of
TNF-a-dependent NF-jB activation by DGKa.
siRNA-mediated knockdown of DGKa failed to show detectable
effects on IjB phosphorylation and its degradation (Fig. 1 and Sup-
plementary Fig. 1). Moreover, the phosphorylation levels of Ser468
and Ser536 in NF-jB were not affected by DGKa depletion (Fig. 2).
Thus, it is likely that DGKa selectively regulates the PKCf-mediated
Ser311 phosphorylation of p65. p65 is known to have several other
phosphorylation sites, such as Ser276 and Ser529 [9,10]. Because
the PKCf-mediated phosphorylation at Ser311 was reported to be
critical for TNF-a-induced activation of NF-jB [13], Ser311 phos-
phorylation is, at least in part, essential for DGKa-regulated NF-
jB activation.
Our results did not show whether PKCf acted upstream or
downstream of DGKa. However, because it was reported that PKCf
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Fig. 4. Effects of overexpression and knockdown of PKCf on NF-jB activity
enhanced by DGKa overexpression in AKI melanoma cells. (A and B) AKI melanoma
cells were transfected with either control or PKCf siRNA as indicated. After 24 h,
cells were cotransfected with pNF-jB-Luc vector (Clontech-Takara Bio, 40 ng/ml),
pSV-b-galactosidase control vector (Clontech-Takara Bio, 40 ng/ml), and with either
GFP or GFP-DGKa expression plasmids (120 ng/ml) as indicated. After 24 h, cells
were further incubated with or without 50 ng/ml of TNF-a for 12 h. (A) Luciferase
activity was measured and normalized to b-galactosidase activity. The results are
presented as the percentage of the value of control siRNA plus GFP (TNF-a (+)) and
represent the mean ± S.D. of the values obtained in three separate experiments.
Statistical signiﬁcance was determined using Student’s t-test. (B) Cell lysates (10 lg
of protein) were analyzed by Western blotting with antibodies against PKCf, GFP,
actin, and p65 as indicated. (C) AKI melanoma cells were cotransfected with pNF-
jB-Luc vector (40 ng/ml), pSV-b-galactosidase control vector (40 ng/ml), and the
indicated combinations of expression plasmids (60 ng/ml each): GFP (), GFP-
DGKa (DGKa (+)), and GFP-PKCf (PKCf (+)). After 24 h, cells were further incubated
with or without 50 ng/ml of TNF-a for 12 h. Luciferase activity was measured and
was normalized to b-galactosidase activity. The results are presented as the
percentage of the value of control transfection (TNF-a (+)) and represent the
means ± S.D. of the values obtained in three separate experiments.
3268 M. Kai et al. / FEBS Letters 583 (2009) 3265–3268directly phosphorylated p65 [13], DGKa is probably an upstream
regulator of PKCf. Interestingly, phosphatidic acid was reported
to activate PKCf directly in vitro [15]. However, it is not clear at
present whether phosphatidic acid produced by DGKa directly
activates PKCf. We cannot rule out the possibility of other factors
bridging between DGKa and PKCf.
The transcription factor NF-jB is a crucial regulator of many
physiological and pathological processes, including control of the
adaptive and innate immune responses, inﬂammation, prolifera-
tion, tumorigenesis, and apoptosis. Thus, the tight regulation of
NF-jB activity within a cell is extremely important. However, the
regulatory mechanisms are not yet fully elucidated. For example,
upstream regulators of PKCf-dependent NF-jB activation [13]
have not been identiﬁed. The results of the present study strongly
suggest that DGKa is an upstream regulator. Further study on the
mechanism underlying the DGKa–PKCf signaling pathway is
needed to better understand the complex regulation of the impor-
tant signaling hub NF-jB.Acknowledgments
This study was partly supported by grants from the Ministry of
Education, Culture, Sports, Science and Technology of Japan, the
Northern Advancement Center for Science and Technology of Hok-
kaido, Japan, the Japan Diabetes Foundation, the Suhara Memorial
Foundation, Novo Nordisk Pharma Ltd. (Japan), the Takeda Science
Foundation, the Suzuken Memorial Foundation, and the Akiyama
Foundation.Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2009.09.017.References
[1] Merida, I., Avila-Flores, A. and Merino, E. (2008) Diacylglycerol kinases: at the
hub of cell signalling. Biochem. J. 409, 1–18.
[2] Sakane, F., Imai, S., Kai, M., Yasuda, S. and Kanoh, H. (2007) Diacylglycerol
kinases: why so many of them? Biochim. Biophys. Acta 1771, 793–806.
[3] Topham, M.K. (2006) Signaling roles of diacylglycerol kinases. J. Cell. Biochem.
97, 474–484.
[4] van Blitterswijk, W.J. and Houssa, B. (2000) Properties and functions of
diacylglycerol kinases. Cell. Signal. 12, 595–605.
[5] Kazanietz, M.G. (2002) Novel ‘‘nonkinase” phorbol ester receptors: the C1
domain connection. Mol. Pharmacol. 61, 759–767.
[6] Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and
activation of protein kinase C. Science 258, 607–614.
[7] Exton, J.H. (1999) Regulation of phospholipase D. Biochim. Biophys. Acta 1439,
121–133.
[8] Yanagisawa, K. et al. (2007) Diacylglycerol kinase a suppresses tumor necrosis
factor-a-induced apoptosis of human melanoma cells through NF-jB
activation. Biochim. Biophys. Acta 1771, 462–474.
[9] Chen, L.F. and Greene, W.C. (2004) Shaping the nuclear action of NF-jB. Nat.
Rev. Mol. Cell Biol. 5, 392–401.
[10] Neumann, M. and Naumann, M. (2007) Beyond IjBs: alternative regulation of
NF-jB activity. FASEB J. 21, 2642–2654.
[11] Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T. and Toriumi, W. (1999) IjB
kinases phosphorylate NF-jB p65 subunit on serine 536 in the transactivation
domain. J. Biol. Chem. 274, 30353–30356.
[12] Schwabe, R.F. and Sakurai, H. (2005) IKKb phosphorylates p65 at S468 in
transactivaton domain 2. FASEB J. 19, 1758–1760.
[13] Duran, A., Diaz-Meco, M.T. and Moscat, J. (2003) Essential role of RelA Ser311
phosphorylation by fPKC in NF-jB transcriptional activation. EMBO J. 22,
3910–3918.
[14] Kanoh, H., Iwata, T., Ono, T. and Suzuki, T. (1986) Immunological
characterization of sn-1,2-diacylglycerol and sn-2-monoacylglycerol kinase
from pig brain. J. Biol. Chem. 261, 5597–5602.
[15] Limatola, C., Schaap, D., Moolenaar, W.H. and van Blitterswijk, W.J. (1994)
Phosphatidic acid activation of protein kinase C f overexpressed in COS cells:
comparison with other protein kinase C isotypes and other acidic lipids.
Biochem. J. 304, 1001–1008.
